Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 11:41 PM UTC
| NCT Number | NCT06096974 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Shanghai YingLi Pharmaceutical Co. Ltd. |
| Last Updated on CT.gov | April 9, 2025 (Apr 9, 2025) |
As of August 31, 2026: Clinical trial NCT06096974 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 3 locations across the United States. The study is sponsored by Shanghai YingLi Pharmaceutical Co. Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06096974 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06096974 was last updated Apr 9, 2025 (April 9, 2025). HelloStudys verifies this status automatically.